CDKL5 and epilepsy: The discrepancy between humans and mice is currently difficult to explain, however the common features of CDD and RTT suggest that the epilepsy in both conditions may be due to alterations in pathways that can be affected differently to the primary gene defect (CDKL5 or MECP2 mutation) in humans and in mice.